Critical Safety Gaps for Mental Health Applications Unknown effects on cognitive function, memory, personality, mood stability beyond intended therapeutic effect Long-term impacts on brain chemistry (chronic administration effects unexplored beyond 6 weeks in animals) Potential for psychological dependence or tolerance (not studied systematically) Impacts on developing brains in adolescents and young adults (completely unknown with no pediatric studies) Drug Interactions Pose Serious Concerns BPC-157s simultaneous effects on serotonin, dopamine, GABA, glutamate, and nitric oxide systems create multiple theoretical interaction points with psychiatric medications, yet interactions are not well studied. Specific concerns include: With SSRIs and SNRIs: Risk of serotonin syndrome is genuine
Food and Drug Administration (2024) FDAs concerns with unapproved GLP-1 drugs used for weight loss, U.S
Disclaimer: This product is intended strictly for research and laboratory use only
503A pharmacy source matters: The before and after results we see at our clinic come from pharmaceutical-grade 503A compounded BPC-157
MIC is actually a combination of 3 non-vitamin compounds: Methionine, Inositol, and Choline Chloride
Is a prescription required for B12 injections